Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Merck Sharp & Dohme Limited
Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 14/03/2012
PIL Restandol Testocaps 40 mg capsule, soft

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 14/03/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 27/09/2011 and displayed until 14/03/2012
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 17/02/2010 and displayed until 27/09/2011
Reasons for adding or updating:
  • Correction of spelling/typing errors
  • Change to side-effects
Updated on 05/02/2010 and displayed until 17/02/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 30/06/2009 and displayed until 05/02/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 10/04/2008 and displayed until 30/06/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 29/02/2008 and displayed until 10/04/2008
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to appearance of the medicine
  • Change to packaging
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
  • Change to date of revision
  • Change to how to administer the medicine
  • Change of product licence name
Updated on 28/01/2002 and displayed until 29/02/2008
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
  testosterone undecanoate